Structure | Chemical Name | CAS | MF |
|
N-(9H-carbazol-3-yl)acetamide
|
|
C14H12N2O
|
|
N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-4-methyl-N-(4-methylphenyl)benzenesulfonamide
|
312599-45-4
|
C29H28N2O3S
|
|
N-(9H-carbazol-9-yl)-4-nitrobenzamide
|
|
C19H13N3O3
|
|
N-[2-(9H-carbazol-9-yl)-2-oxoethyl]-4-methoxyaniline
|
522659-66-1
|
C21H18N2O2
|
|
N-[2-(9H-carbazol-9-yl)-2-oxoethyl]-N-(4-ethoxyphenyl)amine
|
|
C22H20N2O2
|
|
N-[3-(9H-carbazol-9-yl)-2-hydroxypropyl]-N-(4-chlorophenyl)methanesulfonamide
|
309928-51-6
|
C22H21ClN2O3S
|
|
NH2-(BOC)-PEG RESIN
|
|
|
|
N(G)-methylagmatine
|
77414-15-4
|
C6H16N4
|
|
1-NH2-CGMP SODIUM SALT
|
78033-42-8
|
C10H12N6NaO7P
|
|
N-(5H-chromeno[4,3-d]pyrimidin-2-yl)-4-nitrobenzenecarboxamide
|
|
C18H12N4O4
|
|
N'-(5H-CHROMENO[4,3-D]PYRIMIDIN-2-YL)-N,N-DIMETHYLIMINOFORMAMIDE
|
866142-90-7
|
C14H14N4O
|
|
N-(5H-CHROMENO[4,3-D]PYRIMIDIN-2-YL)-3-NITROBENZENECARBOXAMIDE
|
866041-29-4
|
C18H12N4O4
|
|
N-(5H-CHROMENO[4,3-D]PYRIMIDIN-2-YL)-2-FLUOROBENZENECARBOXAMIDE
|
866048-82-0
|
C18H12FN3O2
|
|
N-(5H-CHROMENO[4,3-D]PYRIMIDIN-2-YL)-4-FLUOROBENZENECARBOXAMIDE
|
866041-31-8
|
C18H12FN3O2
|
|
N-(5H-CHROMENO[4,3-D]PYRIMIDIN-2-YL)-N'-[(4-METHYLBENZYL)OXY]IMINOFORMAMIDE
|
866142-92-9
|
C20H18N4O2
|
|
N-(5H-CHROMENO[4,3-D]PYRIMIDIN-2-YL)-N'-[(4-FLUOROBENZYL)OXY]IMINOFORMAMIDE
|
866142-93-0
|
C19H15FN4O2
|
|
N-(5H-CHROMENO[4,3-D]PYRIMIDIN-2-YL)-4-METHYLBENZENECARBOXAMIDE
|
866041-30-7
|
C19H15N3O2
|
|
N-(β-Glucopyranosyl)-N2-acetyl-S-nitrosopenicillaMide
|
214193-25-6
|
C13H23N3O8S
|
|
N(4)-glucopyranosylsulfamethazine
|
55101-26-3
|
C18H24N4O7S
|
|
N-(glucitol)ethanolamine
|
|
|
|
N-glucopyranosyl-N2-acetyl-S-nitrosopenicillaminamide
|
|
C13H23N3O8S
|
|
N-gluconylglycine
|
|
C8H17NO7
|
|
N-Glucosylpolyfungin
|
65805-34-7
|
|
|
N-glucopyranosyl-5-aminosalicylic acid
|
123135-21-7
|
C13H17NO8
|
|
N-glucopyranosylnicotinic acid
|
|
C12H17NO7
|
|
N-(4-glucuronyl-3-nitrobenzyloxycarbonyl)doxorubicin
|
|
|
|
Nε-γGlu-L-Lys-OH
|
|
|
|
Nhdc
|
|
|
|
N-GLUTARYL-L -PHENYLALANINE-BETA-NAPHTHYLAMIDE
|
|
C24H25N3O4
|
|
N-GLUTARYL-L-PHENYLALANINE P-NITROANILIDE
|
5800-34-0
|
C20H21N3O6
|
|
N1-GLUTATHIONYL-SPERMIDINE DISULFIDE
|
108081-77-2
|
C34H66N12O10S2
|
|
N-GLUTARYL-GLY-PHE 4-METHOXY-BETA-NAPHTHYLAMIDE
|
100940-58-7
|
C27H30N4O6
|
|
N-glutarylphosphatidylethanolamine
|
|
|
|
6-(N-glutarylphenylalanylamido)quinoline
|
80115-54-4
|
C23H23N3O4
|
|
N-glutarylmonascorubramine
|
|
|
|
N'-(glutathion-S-yl)-N-acetylbenzidine S-oxide
|
|
|
|
N-(α-Glutamyl)palmitamide
|
|
|
|
N-(γ-Glutamyl)-S-methylcysteine
|
|
|
|
N-(γ-Glutamyl)acetamide
|
|
|
|
N-[(2-2H)-2-Butenyl]-N-butylacetamide
|
|
C10H19NO
|
|
NfxB protein
|
|
|
|
N-GLYCYL-L-TYROSINE HYDRATE, 97
|
207300-83-2
|
C11H16N2O5
|
|
1-N-glycidyl-5-fluoro-indole
|
247915-89-5
|
C11H10FNO
|
|
N-Glycinyl-1-deoxy-D-glucitol
|
|
C8H17NO7
|
|
N-glycine Maleic acid aMide
|
|
C6H9N3O4
|
|
N-GLYCYLMUSCIMOL HYDROBROMIDE
|
103871-75-6
|
C6H10BrN3O3
|
|
N'-GLYCOLOYL-2,3-DIHYDRO-1,4-BENZODIOXINE-2-CARBOHYDRAZIDE
|
|
C11H12N2O5
|
|
N'-GLYCOLOYL-3-NITROBENZOHYDRAZIDE
|
|
C9H9N3O5
|
|
N-Glycolylneuraminic acid
|
1113-83-3
|
C11H19NO10
|
|
N-Glycylglycine ion(-1)
|
|
C4H7N2O3-1
|
|
N-Glycylglycine
|
556-50-3
|
C4H8N2O3
|
|
N'-GLYCOLOYLBENZOHYDRAZIDE
|
|
C9H10N2O3
|
|
N-glycylglycyl-S-acetylcysteamine trifluoroacetate
|
96538-33-9
|
C10H16F3N3O5S
|
|
N-(4-GLYCOLOYLPHENYL)METHANESULFONAMIDE
|
|
C9H11NO4S
|
|
N-(4-GLYCOLOYLPHENYL)-2,2-DIMETHYLPROPANAMIDE
|
|
C13H17NO3
|
|
4-N-glycyllysinomicin
|
84373-74-0
|
C24H47N7O9
|
|
N-GLYCOLOYLBENZAMIDE
|
|
C9H9NO3
|
|
N-(4-GLYCOLOYLPHENYL)-2-METHYLPROPANAMIDE
|
|
C12H15NO3
|
|
N-glycylglycine hydrochloride
|
23851-28-7
|
C4H9ClN2O3
|
|
N-Glycan Acceptor Substrate, Pyridylaminated, Asialo.
|
|
|
|
4-N-glycyl sannamycin C
|
|
|
|
N-GLYCOLYLNEURAMINIC ACID
|
|
C11H19NO10
|
|
N-(4-GLYCOLOYLPHENYL)BENZAMIDE
|
|
C15H13NO3
|
|
N-[(5-GLYCOLOYLTHIEN-2-YL)METHYL]ACETAMIDE
|
|
C9H11NO3S
|
|
N-GLYCAN ACCEPTOR SUBSTRATE, GLYCOPEPTIDES, ASIALO, AGALACTO, BIANTENNARY
|
|
|
|
N-(4-GLYCIDYLOXYPHENYL)-PROPAMIDE
|
|
C12H15NO3
|
|
N-[(5-GLYCOLOYL-2-FURYL)METHYL]ACETAMIDE
|
|
C9H11NO4
|
|
N-Glycan Acceptor Substrate, Pyridylaminated, Common Core.
|
|
|
|
N-Glycinylmaleamic acid
|
54930-24-4
|
C6H7NO5
|
|
N-Glycyl-L-leucine
|
869-19-2
|
C8H16N2O3
|
|
N-GLYCYL-DL-2-AMINOBUTYRIC ACID
|
7369-76-8
|
C6H12N2O3
|
|
N-(glycyl-histidyl-lysyl)-2-(4''-methoxycarbonyl-2'',4'-bithiazol-2'-yl)ethylamine
|
121034-90-0
|
C24H33N9O5S2
|
|
N-Glycyl-L-glutamine
|
|
C7H13N3O4
|
|
N-glycyl-L-aspartic acid
|
|
C6H10N2O5
|
|
N-Glycyglycine
|
|
C4H8N2O3
|
|
N-glycolylmannosamine pentaacetate
|
|
C18H25NO12
|
|
N-glycosylpolyfungin
|
|
|
|
N-glycosylsialoparagloboside
|
72626-26-7
|
|
|
N-Glycan Acceptor Substrate, Glycopeptides, Asialo.
|
|
|
|
N-Glycyl-L-glutamine monohydrate
|
|
C7H15N3O5
|
|
N-glycosyltransferase
|
|
|
|
N-glycan alpha-2,8-sialyltransferase IV
|
|
|
|
N-GLYCOLOYL-2-METHOXYBENZAMIDE
|
|
C10H11NO4
|
|
N-Glycyl-L-tyrosine dihydrate
|
|
C11H18N2O6
|
|
N-Glycylanilide
|
|
C8H10N2O.2H2O
|
|
N-GLYCYL-G-AMINOBUTYRICACID
|
|
C6H12N2O3
|
|
N'-GLYCOLOYL-2-FUROHYDRAZIDE
|
|
C7H8N2O4
|
|
N-Glycan Acceptor Substrate, Dabsylated Tetrapeptide, Asial.
|
|
|
|
N-[3-(Glycylamino)butyryl]glycine
|
|
C8H15N3O4
|
|
N-Glycidylbenzamide
|
|
C10H11NO2
|
|
N-Glycylstearamide
|
|
C20H40N2O2
|
|
N-Glycolyl-8-O-methylneuraminic acid
|
|
C12H21NO10
|
|
(+)-N-Glycyl-D-norleucine
|
|
C8H16N2O3
|
|
N-(4-GLYCOLOYLPHENYL)ACETAMIDE
|
|
C10H11NO3
|
|
N-[4-(2-glycoloylcarbohydrazonoyl)phenyl]acetamide
|
491586-57-3
|
C11H13N3O3
|
|
N-GLYCOLOYLNEURAMINIC ACID AMMONIUM SALT
|
|
C11H22N2O10
|
|
N'-GLYCOLOYL-4-NITROBENZOHYDRAZIDE
|
|
C9H9N3O5
|
|
N-(4-GLYCOLOYLPHENYL)PROPANAMIDE
|
|
C11H13NO3
|
|
N-(4-GLYCOLOYLBENZYL)ACETAMIDE
|
|
C11H13NO3
|
|
N-GLYCOLOYL-3-NITROBENZAMIDE
|
|
C9H8N2O5
|